company background image
3164 logo

GenMont Biotech Incorporation TWSE:3164 Stock Report

Last Price

NT$24.45

Market Cap

NT$2.1b

7D

-0.6%

1Y

-2.8%

Updated

13 Jun, 2024

Data

Company Financials

GenMont Biotech Incorporation

TWSE:3164 Stock Report

Market Cap: NT$2.1b

GenMont Biotech Incorporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for GenMont Biotech Incorporation
Historical stock prices
Current Share PriceNT$24.45
52 Week HighNT$25.85
52 Week LowNT$21.40
Beta0.36
1 Month Change3.16%
3 Month Change8.43%
1 Year Change-2.78%
3 Year Change-6.14%
5 Year Change-6.32%
Change since IPO-17.86%

Recent News & Updates

We Think That There Are More Issues For GenMont Biotech Incorporation (TWSE:3164) Than Just Sluggish Earnings

Mar 19
We Think That There Are More Issues For GenMont Biotech Incorporation (TWSE:3164) Than Just Sluggish Earnings

Recent updates

We Think That There Are More Issues For GenMont Biotech Incorporation (TWSE:3164) Than Just Sluggish Earnings

Mar 19
We Think That There Are More Issues For GenMont Biotech Incorporation (TWSE:3164) Than Just Sluggish Earnings

Should You Or Shouldn't You: A Dividend Analysis on GenMont Biotech Incorporation (TPE:3164)

Apr 04
Should You Or Shouldn't You: A Dividend Analysis on GenMont Biotech Incorporation (TPE:3164)

GenMont Biotech Incorporation's(TPE:3164) Share Price Is Down 26% Over The Past Five Years.

Feb 14
GenMont Biotech Incorporation's(TPE:3164) Share Price Is Down 26% Over The Past Five Years.

Is GenMont Biotech Incorporation's (TPE:3164) Recent Price Movement Underpinned By Its Weak Fundamentals?

Jan 24
Is GenMont Biotech Incorporation's (TPE:3164) Recent Price Movement Underpinned By Its Weak Fundamentals?

Tread With Caution Around GenMont Biotech Incorporation's (TPE:3164) 3.5% Dividend Yield

Jan 03
Tread With Caution Around GenMont Biotech Incorporation's (TPE:3164) 3.5% Dividend Yield

Are GenMont Biotech Incorporation's (TPE:3164) Statutory Earnings A Good Guide To Its Underlying Profitability?

Dec 08
Are GenMont Biotech Incorporation's (TPE:3164) Statutory Earnings A Good Guide To Its Underlying Profitability?

Shareholder Returns

3164TW BiotechsTW Market
7D-0.6%0.5%2.5%
1Y-2.8%-3.5%26.3%

Return vs Industry: 3164 matched the TW Biotechs industry which returned -3.5% over the past year.

Return vs Market: 3164 underperformed the TW Market which returned 26.3% over the past year.

Price Volatility

Is 3164's price volatile compared to industry and market?
3164 volatility
3164 Average Weekly Movement2.6%
Biotechs Industry Average Movement4.9%
Market Average Movement4.7%
10% most volatile stocks in TW Market8.5%
10% least volatile stocks in TW Market2.2%

Stable Share Price: 3164 has not had significant price volatility in the past 3 months.

Volatility Over Time: 3164's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000n/an/awww.genmont.com.tw

GenMont Biotech Incorporation engages in the research, development, manufacture, and sale of functional probiotic supplements in Taiwan. The company offers functional probiotics raw materials, capsules, powder, tablets, and liquid products; and original formula design and manufacturing, and equipment manufacturing services on health care food, as well as cooperates in the research, production, and clinical trial of various products. GenMont Biotech Incorporation was founded in 2000 and is headquartered in Tainan City, Taiwan.

GenMont Biotech Incorporation Fundamentals Summary

How do GenMont Biotech Incorporation's earnings and revenue compare to its market cap?
3164 fundamental statistics
Market capNT$2.12b
Earnings (TTM)NT$59.50m
Revenue (TTM)NT$354.81m

35.6x

P/E Ratio

6.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
3164 income statement (TTM)
RevenueNT$354.81m
Cost of RevenueNT$117.77m
Gross ProfitNT$237.04m
Other ExpensesNT$177.54m
EarningsNT$59.50m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.69
Gross Margin66.81%
Net Profit Margin16.77%
Debt/Equity Ratio4.4%

How did 3164 perform over the long term?

See historical performance and comparison

Dividends

2.9%

Current Dividend Yield

124%

Payout Ratio

Does 3164 pay a reliable dividends?

See 3164 dividend history and benchmarks
When do you need to buy 3164 by to receive an upcoming dividend?
GenMont Biotech Incorporation dividend dates
Ex Dividend DateJun 17 2024
Dividend Pay DateJul 10 2024
Days until Ex dividend4 days
Days until Dividend pay date27 days

Does 3164 pay a reliable dividends?

See 3164 dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.